These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 446264)

  • 41. Bioavailability of parenteral drugs I. Intravenous and intramuscular doses.
    Tse FL; Welling PG
    J Parenter Drug Assoc; 1980; 34(5):409-21. PubMed ID: 6905871
    [No Abstract]   [Full Text] [Related]  

  • 42. [Demonstration of pharmacokinetic models using analog computers].
    von Hattingberg HM
    Arzneimittelforschung; 1972 Feb; 22(2):305-10. PubMed ID: 5067481
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pharmacokinetics and compartmental analysis].
    Grégoire F
    J Pharm Belg; 1972; 27(5):631-47. PubMed ID: 4660651
    [No Abstract]   [Full Text] [Related]  

  • 44. Simulation package for multiple intravenous infusions of two compartment pharmacokinetic drugs.
    Wurster DE; Shrewsbury RP
    Int J Biomed Comput; 1981 Nov; 12(6):455-70. PubMed ID: 7319664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of multiple-dose blood level curves of drugs administered four times daily at non-uniform dosing intervals.
    Ng PK
    Int J Biomed Comput; 1981 May; 12(3):217-26. PubMed ID: 7251215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time to reach steady state and prediction of steady-state concentrations for drugs obeying Michaelis-Menten elimination kinetics.
    Wagner JG
    J Pharmacokinet Biopharm; 1978 Jun; 6(3):209-25. PubMed ID: 671227
    [No Abstract]   [Full Text] [Related]  

  • 47. A timely reassessment of early prediction in the bioavailability of orally administered drugs.
    Larsen T; Link A
    Angew Chem Int Ed Engl; 2005 Jul; 44(29):4432-4. PubMed ID: 15984039
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of a programmable hand-held calculator for clinical pharmacokinetics.
    Foster TS; Bourne DW
    Am J Hosp Pharm; 1977 Jan; 34(1):70-5. PubMed ID: 831476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactive simulator for pharmacokinetics of repetitive drug dosing.
    Iben GA; Anderson JH
    Comput Programs Biomed; 1975 Mar; 4(3):113-20. PubMed ID: 1139911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic studies on proxyphylline administered intravenously and orally to man.
    Graffner C; Johnsson G; Sjögren J
    Acta Pharm Suec; 1973 Dec; 10(6):425-34. PubMed ID: 4773111
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacokinetics and their clinical significance.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):193-6. PubMed ID: 5357862
    [No Abstract]   [Full Text] [Related]  

  • 52. A theoretical approach to structure-activity relationships. Some implications for the concept of optimal lipophilicity [proceedings].
    Dearden JC; Townend MS
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():13P. PubMed ID: 12286
    [No Abstract]   [Full Text] [Related]  

  • 53. The i.v. administration of drugs.
    Norman J
    Br J Anaesth; 1983 Nov; 55(11):1049-52. PubMed ID: 6416280
    [No Abstract]   [Full Text] [Related]  

  • 54. General theory for rapidly establishing steady state drug concentrations using two consecutive constant rate intravenous infusions.
    Vaughan DP; Tucker GT
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):235-8. PubMed ID: 1233268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dosage regimen design.
    DeVane CL; Jusko WJ
    Pharmacol Ther; 1982; 17(2):143-63. PubMed ID: 6757976
    [No Abstract]   [Full Text] [Related]  

  • 56. Letter: Absolute drug bioavailability: approximation without comparison to parenteral dose for compounds exhibiting perturbable renal clearance.
    Lalka D; Feldman H
    J Pharm Sci; 1974 Nov; 63(11):1812. PubMed ID: 4427254
    [No Abstract]   [Full Text] [Related]  

  • 57. Infusion therapy.
    Sheppard LC
    Med Instrum; 1983; 17(4):265-6. PubMed ID: 6355786
    [No Abstract]   [Full Text] [Related]  

  • 58. Rapid attainment of successively higher steady-state plasma levels using the Wagner two-step infusion method.
    Zimmerman JJ
    J Pharm Sci; 1978 Dec; 67(12):1651-6. PubMed ID: 722475
    [No Abstract]   [Full Text] [Related]  

  • 59. Noncompartmental determination of the steady-state volume of distribution for any mode of administration.
    Perrier D; Mayersohn M
    J Pharm Sci; 1982 Mar; 71(3):372-3. PubMed ID: 7069605
    [No Abstract]   [Full Text] [Related]  

  • 60. Optimal dosage regimen calculation program based on the remaining drug concentrations in plasma.
    Takada K; Yoshikawa H; Muranishi S
    Int J Biomed Comput; 1985 May; 16(3-4):267-75. PubMed ID: 3839212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.